Form 4: Sensus Healthcare Executive Michael Sardano Acquires 40,000 Shares of Restricted Stock

Michael Sardano, President and General Counsel of Sensus Healthcare, acquired 40,000 shares of restricted stock, with a portion vesting immediately and the remainder vesting over three years.

Summary

• Michael Sardano, President and General Counsel of Sensus Healthcare, acquired 40,000 shares of restricted stock on December 17, 2024.
• 10,000 of these shares vested immediately upon grant.
• The remaining 30,000 shares will vest in three equal annual installments starting on the first anniversary of the grant date.
• The shares were granted under the Sensus Healthcare, Inc. 2017 Equity Incentive Plan.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, which is generally viewed positively as it aligns management interests with shareholders. There is no indication of any negative sentiment.

Positives

• The grant of restricted stock to a key executive aligns their interests with the long-term success of the company.
• The vesting schedule encourages continued service and performance from the executive.

Industry Context

This type of stock grant is a common practice in the healthcare industry to incentivize and retain key executives.

Comparison to Industry Standards

• Stock grants are a standard form of compensation for executives in publicly traded companies, particularly in the healthcare sector.
• Vesting schedules, such as the three-year vesting period described, are also common to ensure long-term commitment from executives.
• Many companies in the medical device and healthcare technology space use similar equity incentive plans to align executive interests with shareholder value.

Stakeholder Impact

• The stock grant aligns the executive's interests with those of shareholders, potentially leading to increased focus on long-term value creation.
• The vesting schedule encourages the executive's continued service, which can benefit the company and its stakeholders.

Key Dates

Keywords

Sensus Healthcare, restricted stock, equity incentive plan, executive compensation, insider trading, stock grant, vesting